Community-acquired Pneumonia research hub
5 indexed studies · 4 currently recruiting
- recruitingPHASE3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
This study is testing a new medicine, Trimodulin, for severe lung infection (pneumonia) in hospital. It will compare Trimodulin to a dummy medicine to see if it makes people better and is safe when used with usual treatments.
United States · Argentina · Australia - recruiting
Epidemiological Study on Community Acquired Pneumonia
This study looks at pneumonia caught outside hospital. Researchers want to understand it better, including what causes it and how it affects people with other health problems. They will follow patients for six months to learn more about this common lung infection.
Germany - recruitingPHASE2, PHASE3
Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.
Doctors are studying if giving children with pneumonia antibiotic medicine twice a day works as well as giving it three times a day. They want to find the best and easiest way to treat non-serious lung infections.
Canada - recruitingPHASE3
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
This study is testing if an antiviral medicine, acyclovir, helps seriously ill patients in intensive care with pneumonia and the herpes simplex virus (which causes cold sores). We want to find out if treating this virus improves their chances of recovery.
Germany - authorisedTherapeutic exploratory (Phase II)
Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2)
This study is looking at new ways to treat pneumonia, a serious chest infection. We want to see if delivering antibiotics directly to the lungs, or using different antibiotics, helps people recover faster and spend less time in hospital. It's a key step in finding better treatments.
Denmark